MonTa Biosciences ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About MonTa Biosciences ApS
MonTa Biosciences ApS (CVR number: 36697016) is a company from LYNGBY-TAARBÆK. The company recorded a gross profit of 1479.6 kDKK in 2024. The operating profit was -2053.2 kDKK, while net earnings were -3920.6 kDKK. The profitability of the company measured by Return on Assets (ROA) was -2.4 %, which can be considered poor and Return on Equity (ROE) was -5 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -6.2 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. MonTa Biosciences ApS's liquidity measured by quick ratio was 5.8 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -12 136.62 | 2 130.49 | 1 756.94 | 2 024.63 | 1 479.57 |
EBIT | -15 654.95 | -1 318.07 | -1 324.72 | -1 749.10 | -2 053.25 |
Net earnings | -13 292.78 | 1 406.26 | -1 439.14 | -3 278.63 | -3 920.57 |
Shareholders equity total | 1 704.38 | 3 110.64 | 1 671.50 | -1 607.12 | -5 527.70 |
Balance sheet total (assets) | 20 395.21 | 35 016.05 | 49 154.10 | 74 026.63 | 83 383.70 |
Net debt | 10 392.85 | 28 130.78 | 39 817.33 | 57 491.14 | 77 177.23 |
Profitability | |||||
EBIT-% | |||||
ROA | -87.6 % | -4.8 % | -3.1 % | -2.8 % | -2.4 % |
ROE | -159.2 % | 58.4 % | -60.2 % | -8.7 % | -5.0 % |
ROI | -90.6 % | -4.9 % | -3.2 % | -2.8 % | -2.5 % |
Economic value added (EVA) | -13 405.94 | -1 914.90 | -2 673.01 | -3 702.50 | -5 153.97 |
Solvency | |||||
Equity ratio | 8.4 % | 8.9 % | 3.4 % | -2.1 % | -6.2 % |
Gearing | 920.4 % | 962.0 % | 2622.0 % | -4396.9 % | -1520.6 % |
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 11.9 | 18.9 | 20.2 | 14.1 | 5.8 |
Current ratio | 11.9 | 18.9 | 20.2 | 14.1 | 5.8 |
Cash and cash equivalents | 5 293.45 | 1 793.47 | 4 009.93 | 13 172.01 | 6 877.71 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BBB | BBB | BBB | BBB |
Variable visualization
Roles
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.